Page 177 - 2022 Ranger Medic Handbook
P. 177

METHOCARBOMOL (ROBAXIN)
         Class: Somatic nervous system agent – central-acting, skeletal muscle relaxant
         Action: Causes skeletal muscle relaxation by general CNS depression
         Dose: 500mg up to 1.5g PO qid × 2–3 days; 500mg recommended starting dose
         Indications: For management of discomfort associated with acute musculoskeletal disorders as adjunct to physical
         therapy and other measures
         Contraindications: Comatose; CNS depression; acidosis, kidney dysfunction; pregnancy category caution advised
         during pregnancy and consider alternative while breastfeeding
         Adverse/Side-effects: Fever, anaphylactic reaction, flushing, syncope, convulsions; urticaria, pruritus, rash, thrombo-
         phlebitis, pain, sloughing; conjunctivitis, blurred vision, nasal congestion; drowsiness, dizziness, light-headedness,
         headache; hypotension, bradycardia; nausea, metallic taste
         Interactions: Alcohol and other CNS depressants enhance CNS depression
         Mission Impact: GROUNDING medication for personnel on flight status


         METHYLPREDNISOLONE (SOLU-MEDROL)                                    SECTION 4
         Class: Hormones and synthetic substitutes – adrenal corticosteroid, glucocorticosteroid, anti-inflammatory
         Action: Intermediate-acting synthetic steroid with less sodium and water retention effects than hydrocortisone; inhib-
         its phagocytosis and release of allergic substances; modifies immune response to various stimuli; anti-inflammatory
         and immunosuppressive
         Dose: 125mg IV q6hr or 150mg IM q6hr
         Indications: For management of acute and chronic inflammatory diseases, control of severe acute and chronic al-
         lergic processes, acute bronchial asthma.
         Contraindications: Systemic fungal infections; pregnancy category caution advised during pregnancy and may use
         while breastfeeding
         Adverse/Side-effects: Euphoria, headache, insomnia, confusion, psychosis; CHF, edema; nausea, vomiting, peptic
         ulcer; muscle weakness, delayed wound healing, muscle wasting, osteoporosis, aseptic necrosis of bone, spontane-
         ous fractures; cushingoid features, growth suppression in children, carbohydrate intolerance, hyperglycemia; cataracts;
         leukocytosis; hypokalemia
         Interactions: Amphotericin B, furosemide, thiazide diuretics increase potassium loss; may enhance virus replication
         or increase attenuated virus vaccine adverse effects; isoniazid, phenytoin, phenobarbital, rifampin increase metabo-
         lism and decrease effectiveness


















                                           2022 RANGER MEDIC HANDBOOK  163
   172   173   174   175   176   177   178   179   180   181   182